AUSTEDO XR
NDC 68546-473, deutetrabenazine, tablet, film coated, extended release, from Teva Neuroscience, Inc..
- Product NDC
- 68546-473
- Status
- Listed
- Labeler
- Teva Neuroscience, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216354
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68546-473 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEUTETRABENAZINE30 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68546-473-56 | 68546047356 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-473-56) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7ea3c60a-45c7-44cc-afc2-d87fa53993c0NADAC price for package 68546047356
GET /v1/drugs/nadac/68546047356
Use it
Look up 68546-473 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68546-473 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68546-473. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.